Literature DB >> 18768178

Young multiethnic women's attitudes toward the HPV vaccine and HPV vaccination.

Li Ping Wong1.   

Abstract

OBJECTIVE: To investigate the acceptability of the HPV vaccine among a multiethnic sample of young women in Malaysia.
METHODS: A qualitative study of 40 young women aged between 13 and 27 years recruited into 7 focus groups to discuss their knowledge of HPV infection, and their attitudes toward and acceptance of the HPV vaccine. The women were divided into Malay, Chinese, and Indian groups to allow for comparison among ethnicities.
RESULTS: Poor knowledge about HPV did not influence the HPV vaccine's acceptability. Although participants were in favor of the vaccine, the majority preferred to delay vaccination because it is newly introduced, they did not perceive themselves to be at risk of HPV infection, or because of cost factors. Concerns were raised regarding the vaccine's safety, the potential to be perceived as promiscuous and sexually active, and whether the vaccine was halal.
CONCLUSION: Promotion of the HPV vaccine should take account of social and cultural acceptability. The findings will help develop strategies for effective vaccination initiatives in a multiethnic and multireligious Asian society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768178     DOI: 10.1016/j.ijgo.2008.07.005

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  20 in total

1.  Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural southeast Asian women.

Authors:  Li Ping Wong
Journal:  Int J Behav Med       Date:  2011-06

2.  Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician's perspective.

Authors:  Li Ping Wong
Journal:  J Community Health       Date:  2011-02

3.  Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia.

Authors:  Li Ping Wong; Pooi-Fong Wong; Megat Mohamad Amirul Amzar Megat Hashim; Liyuan Han; Yulan Lin; Zhijian Hu; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

Review 4.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

Review 5.  A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.

Authors:  Jennifer D Allen; Gloria D Coronado; Rebecca S Williams; Beth Glenn; Cam Escoffery; Maria Fernandez; Raegan A Tuff; Katherine M Wilson; Patricia Dolan Mullen
Journal:  Vaccine       Date:  2010-04-20       Impact factor: 3.641

Review 6.  Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Authors:  María E Fernández; Jennifer D Allen; Ritesh Mistry; Jessica A Kahn
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

7.  Role of men in promoting the uptake of HPV vaccinations: focus groups' finding from a developing country.

Authors:  Li Ping Wong
Journal:  Int J Public Health       Date:  2009-09-22       Impact factor: 3.380

8.  Awareness and acceptance of human papillomavirus vaccination among health sciences students in Malaysia.

Authors:  Kingston Rajiah; Mari Kannan Maharajan; Nang Sue Chin; Kelly Sze Fang Num
Journal:  Virusdisease       Date:  2015-11-19

9.  Human papillomavirus vaccination: current indications and future directions.

Authors:  Leda Gattoc; Navya Nair; Kevin Ault
Journal:  Obstet Gynecol Clin North Am       Date:  2013-05-10       Impact factor: 2.844

10.  Cervical Cancer Prevention in Malaysia: Knowledge and Attitude of Undergraduate Pharmacy Students Towards Human Papillomavirus Infection, Screening and Vaccination in Malaysia.

Authors:  Mari Kannan Maharajan; Kingston Rajiah; Kelly Num Sze Fang; Lai Yun Lui
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.